Connect with Drug Development Experts for Projects, Phone Consults or Jobs

Submit an anonymous Inquiry -- Start receiving responses within a few hours

Have a need? Explain it here

Forgot password?
Submit Inquiry

By clicking Submit Inquiry you agree to our Terms VIEW

How Zintro Works

  1. 1. Provide a brief description of your needs and Zintro will match it with the most relevant Experts in our 100,000+ user network.
  2. 2. Within a day or two typically 6 - 12 Experts, who have opted-in, will contact you with a brief explanation of their qualifications and how they can help.
  3. 3. You can communicate back and forth, qualify each other and connect through Zintro.
  4. Zintro is free, anonymous and without obligation.

Need Help? A phone icon 1-877-236-7016

Recent Drug Development Inquiries

Area Icon

Clinical Research Organizations (cros)

My firm is doing a diligence project to determine the current growth trends of the market for clinical research organizations (cros). We would also like to understand the effect of the underlying market for r&d drug development and funding for biopharmaceutical companies. We are hoping to speak to clinical research coordinator, project manager, study coordinators, etc., at pharma and biopharma companies who either focus on innovator or generic drug development. Former or current consultants in this role would be helpful. Responsibilities of respondent: familiarity with and understanding of how biopharma and pharmaceutical companies decide which cros to use for early stage clinical research. Will be able to speak to growth trends related to spending on r&d in industry and spending on cro services. To the extent possible, will be able to speak to how this may differ for innovator versus generic drugs. Will be able to speak to the reputations of different cro service providers. The questions we would like to answer: 1) how has your spending on cro early stage services trended in the past few years? What is your outlook for demand for cro services? Why? To the extent you can speak to this, how has this differed for generic vs. Innovator drugs? 2) what is the decision process for determining which cro to use? 3) what factors are considered when determining which cro to use? 4) what are the cros that come to mind? Which cros have you considered? How do cro reputations differ across the different stages of clinical research (early vs. Late)? For different clinical services? 5) what are the trends for cro services moving overseas? Please send a line if you are qualified to answer these questions. Thank you.

  1. Profile Picture

    Lokesh |Asst . Research Director

    Hi! I would be happy to help. I have several years experience working with CROs on clinical trials. ...

    12 Minutes Later
  2. Profile Picture

    Graeme |Director of Pharmacovigilance. PharSafer

    I am happy to discuss this with you from the CRO perspective...

    27 Minutes Later
  3. Profile Picture

    Terrence |Director

    Dear Cshieh, Thank you for contacting me. My name is Terry Cochrane and I am a biopharma professio...

    10 Hours Later
+21 Other Responses
Area Icon

Virologist

I am searching for an independent virologist or md consultant to assist with antiviral drug development --specifically with cmv and hpv early clinical development experience. Please contact me if you feel qualified / interested. Best regards, dave

  1. Profile Picture

    Bruno |CEO

    Dear Dave, I'm an MD consultant previously at Gilead and Syntex/Roche with extensive antiviral exper...

    2.2 Hours Later
  2. Profile Picture

    Jiafen |Research associate

    Hi Dave, I am a virologist and immunologist who has worked with HPV for about 14 years. You can cont...

    2.7 Hours Later
  3. Profile Picture

    Vishal |President & CEO

    My experience of more than 16 years in virology, drug discovery and development along with experienc...

    3.6 Hours Later
+34 Other Responses
Area Icon

Pharma Formulation

Formulation development consultant for pharma industry with 12 to 14 years experience in nce and generics drug product development

  1. Profile Picture

    Klyushnichenko |VP, consultant

    Dear Colleagues, I have extensive experience of Formulation of NCEs and generic drugs. Please see m...

    5 Minutes Later
  2. Profile Picture

    MALCOLM |Owner

    In addition to setting up formulation departments for several generic companies and have been involv...

    11 Minutes Later
  3. Profile Picture

    Steve |Principal Consultant

    I received my PhD in Pharmaceutical Chemistry from The University of Kansas and have very significan...

    14 Minutes Later
+13 Other Responses
Area Icon

Biopharmaceutical Product Development

Seeking an expert or experts to testify to: 1. Good manufacturing practice related to the creation and storage of cell banks and specifically the raw materials used in connection with them. The relevant timeframe is 2003. 2. The practices, procedures and standard operating procedures of biopharmaceutical laboratories related to the creation of master cell banks and the devlopment and testing of new drugs for fda and other countries' approval. 3. The calculation of the damages suffered as a result of an allegedly adulterated master cell bank used in drug development.

  1. Profile Picture

    David |Consultant

    I have the expertise you need. How much time do you estimate is needed?...

    17 Minutes Later
  2. Profile Picture

    suzanne |Member

    I have experience from a FDA regulatory affairs perspective on the requirements for cell banks, to i...

    34 Minutes Later
  3. Profile Picture

    Barry |President/Principle Consultant

    I have worked with clients on production/characterization and storage of master cell banks as both a...

    1.5 Hours Later
+5 Other Responses
Area Icon

Bioanalytical Sciences, Drug Metabolism,

We are looking for experts (one in human drug metabolism and one in animal and human toxicology) to provide summary reviews of the extant literature on two active ingredients, which will be disclosed after a cda is signed. These are oral active agents, with one in rx use for decades and another for food use for a number of years. There is considerable published literature on each active. The review would inform the project team about possible pharm/tox and metabolic studies needed in support of a 505(b)(2) application, as well as the summary write-up for the ind application. Respondents to this search should have hands-on experience in rx drug development and an understanding of fda requirements for drug approval.

  1. Profile Picture

    Barry |President and Managing Partner

    I have over 30 years experience in the area of human drug metabolism. With experience in early drug ...

    26 Minutes Later
  2. Profile Picture

    Jeffrey |President and Managing Director

    I am an MD/PhD basic and clinical pharmacologist with more than 30 years of drug development experie...

    27 Minutes Later
  3. Profile Picture

    May D. |Director

    I am very interested in this project. I am a recently retired bioanalytical, DM/PK R&D scientist wit...

    30 Minutes Later
+20 Other Responses
Area Icon

Preclinical Drug Development

Preclinical cro

  1. Profile Picture

    Marc |Chief Development Officer

    We are a consulting team comprised of Ex-pharma colleagues and have extensive experience with both t...

    5 Minutes Later
  2. Profile Picture

    Costas |CEO

    Dear Sir or Madam, I have extensive experience in all preclinical drug development and have been res...

    15 Minutes Later
  3. Profile Picture

    James |Consultant, Director of Chemistry

    I would bring a strong background in small molecule drug discovery, and management of internal and o...

    16 Minutes Later
+30 Other Responses
Area Icon

Clinical Research Organization (cro)

**please respond to the following request with a proposal if: 1) you currently, or within the last year, work at a pharmaceutical or biotech firm. 2) you are familiar with phase 1 clinical trials. Familiarity with and understanding of how biopharma and pharmaceutical companies decide which cros to use for early stage phase 1 clinical research. Will be able to speak to growth trends related to spending on r&d in industry and spending on cro services. To the extent possible, will be able to speak to how this may differ for innovator versus generic drugs. Will be able to speak to the reputations of different cro service providers for early stage phase 1. 1) how has your spending on cro early stage services trended in the past few years? What is your outlook for demand for cro services? Why? To the extent you can speak to this, how has this differed for generic vs. Innovator drugs? 2) what is the decision process for determining which early stage phase 1 cro to use? 3) what factors are considered when determining which early stage phase 1 cro to use? 4) what are the early stage phase 1 cros that come to mind? Which cros have you considered? How do cro reputations differ across the different stages of clinical research (early vs. Late)? For different clinical services? 5) what are the trends for early stage phase 1 cro services moving overseas? Areas of expertise: seeking experts with knowledge of clinical trials, phase 1-4; clinical trials; early clinical research; cro; early stage clinical research; cros; clinical research organization; clinical research

  1. Profile Picture

    Christine |Project Manager

    Dear Cshieh, I have extensive knowledge and experience working with and selecting CRO's in the Pha...

    26 Minutes Later
  2. Profile Picture

    Lynda |Executive Director, Clinical Trials.

    Hi, I'm expert in Phase I clinical research, I received this request many times. I'm so sorry that I...

    3.5 Hours Later
  3. Profile Picture

    Vadim |Senior Director, Clincal Research

    May discuss this topic...

    1 Day Later
+10 Other Responses
Area Icon

Pharmaceutical Funding

Hi zintro expert, the zintro blog needs you! we are looking for expert opinions on the news mentioned below and would like to include your point of view. We realize your time is valuable, so here is a brief summary of what we are looking for: *a brief answer to the prompt about 1-2 paragraphs including your full name *participation is voluntary no payment will be involved *if chosen, you will be named in the post and we'll include a link to your zintro profile which will generate more visitors for you topic and prompt a yale paper published online on feb. 11 in the journal of global health argues that implementation of a new agency to fund pharmaceutical companies could have decreased the severity of the recent ebola outbreak. Professor of philosophy and international affairs thomas pogge, who is the paper’s lead author, has developed the health impact fund as a way to motivate pharmaceutical companies to produce drugs that will have the greatest global health impact instead of just those that generate a profit. The idea of the fund is for governments to contribute 0.01 to 0.03 percent of their gross national incomes to the fund to support companies in developing drugs that they might not otherwise pursue. This structure would take the buying power of the individuals impacted by a disease out of the equation, making drug development a more equitable process. What are your thoughts? Getting your name and expert opinion published on our blog is a great marketing opportunity. If interested, please send a response to the prompt via znotes within 1-2 days. Don't forget to include your full name. If you have any questions, please let us know. Thank you! the zintro blog team wondering what the post would look like? Here is a sample: http://blog.Zintro.Com/2014/08/14/rosetta-completes-10-year-trip-deep-space />

  1. Profile Picture

    Ram |Senior Biologist/Adjunct Faculty

    I am happy to do this...

    7.2 Hours Later
  2. Profile Picture

    Shen |Zintro Expert

    Dr. Pogge's idea is extremely idealistic and not workable in the real world. He is under the assumpt...

    21.7 Days Later
+2 Other Responses
Area Icon

Translational Science

Biomarker discovery in drug development for oncology

  1. Profile Picture

    Calin |MD

    Advanced Clinical Research Services is a Canadian boutique CRO that provides full clinical research ...

    5 Minutes Later
  2. Profile Picture

    Towia |Director of Genomics and Proteomics Cent

    I am the director of the BIDMC Genomics, Proteomics, Bioinformatics, and Systems Biology Center and ...

    12 Minutes Later
  3. Profile Picture

    Karl |Sr. Principal Scientist

    Please provide details for a contact. Karl-Heinz Ott 609 510 0827...

    13 Minutes Later
+28 Other Responses
Area Icon

Hair Loss Drug Side Effects

Seeking medical expert on hair loss drugs and sexual side effects

  1. Profile Picture

    Suhaib |Experienced Biotechnology/Pharmaceutical

    Do you need a medical (physician) advice or a scientist advice? What is the ultimate aim?...

    38 Minutes Later
  2. Profile Picture

    Samuel |Director - Oncology Early Development

    I"m familiar with these medications, and their side effects (based on my training as a physician and...

    1.2 Hours Later
  3. Profile Picture

    Lorne |Chief Scientific Officer and Business De

    As an expert, researcher and marketer in hair re-growth, I often speak specifically on the side effe...

    3.5 Hours Later
+8 Other Responses
Area Icon

Cytokine

Looking for an expert in cytokine drug development. Interested in assays, especially flow cytometry assays to detect the human cell response to cytokine drugs such as interferon, gcsf, etc

  1. Profile Picture

    Julie |CIO, Director of Services

    Hello. We have expertise in developing in vitro functional cell-based assays for flow cytometry. A...

    5.4 Hours Later
  2. Profile Picture

    onikepe |

    Thank you for your reply. I am interested in FLOW cytometry assays to detect the human cell response...

    2.9 Days Later
  3. Profile Picture

    Geert |CSO managing director

    Yes I can help you with this kind of flow cytometry assays. If you want to proceed, please Accept my...

    3 Days Later
+15 Other Responses
Area Icon

Kpi For Pharma Sales Force

Pharmaceutical sales and marketing developement for medicines in different uses such as anti-infectives,cardiovascular and cns

  1. Profile Picture

    Suhaib |Experienced Biotechnology/Pharmaceutical

    Dear Balnajjar, Thanks for contacting me. What kind of advice are exactly looking? I am a Pharmace...

    24 Minutes Later
  2. Profile Picture

    David |Sokol Professor of Medicinal Chemistry

    I cannot help with this project because my expertise is in the science of drug discovery. good lu...

    38 Minutes Later
  3. Profile Picture

    Charles |Regional Sales Director

    I am interested in doing this consult......

    38 Minutes Later
+9 Other Responses
See More Inquiries

Top Drug Development Experts

See More Experts
Share
LinkedInTwitterFacebookGoogle+